File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: An Asia-Pacific perspective

TitleGlobal Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: An Asia-Pacific perspective
Authors
KeywordsAsia
Bronchodilators
Chronic obstructive pulmonary disease
Global Initiative for Chronic Obstructive Lung Disease statement
Influenza vaccination
Pulmonary rehabilitation
Severe Acute Respitory Syndrome
Spirometry
Issue Date2005
PublisherBlackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/RES
Citation
Respirology, 2005, v. 10 n. 1, p. 9-17 How to Cite?
AbstractChronic obstructive pulmonary disease (COPD) is a major public health problem and its prevalence and mortality are increasing throughout the world, including the Asia-Pacific region. To arrest these worldwide trends, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Expert Panel's global strategy for the diagnosis, management, and prevention of COPD was published in 2001. Based on recently published clinical trials, the GOLD statement was updated in 2003. The Asia-Pacific COPD Roundtable Group, a taskforce of expert respirologists from the Asia-Pacific region, has recently formulated a consensus statement on implementation of the GOLD strategy for COPD in the Asia-Pacific region. The key issues identified by the COPD Roundtable Group for comment are: (i) where there is no access to spirometry, diagnosis of COPD could be suspected on the basis of history, symptoms and physical signs; (ii) inhaled bronchodilators are the preferred regular treatment for COPD in the region, but oral bronchodilators may be considered if the cost of inhaled bronchodilators is a barrier to treatment; (iii) the use of an Metered Dose Inhaler with spacer in place of a nebulizer is recommended in the treatment of acute airflow obstruction in patients with COPD; (iv) influenza vaccination is recommended for all patients with COPD in communities where there is a high likelihood of Severe Acute Respitory Syndrome; and (v) simplified pulmonary rehabilitation programmes should be established in areas where comprehensive programmes are unavailable. Physical exercise training and education on smoking cessation should be core elements of any rehabilitation program. In summary, the COPD Roundtable Group supports, implementation of the GOLD strategy for the diagnosis, management and prevention of COPD in the Asia-Pacific region, subject to the additions and modifications to the guidelines suggested above.
Persistent Identifierhttp://hdl.handle.net/10722/162850
ISSN
2021 Impact Factor: 6.175
2020 SCImago Journal Rankings: 1.857
References

 

DC FieldValueLanguage
dc.contributor.authorWan, CTen_US
dc.contributor.authorMahayiddin, AAen_US
dc.contributor.authorCharoenratanakul, Sen_US
dc.contributor.authorZhong, NSen_US
dc.contributor.authorSeale, Pen_US
dc.contributor.authorIp, Men_US
dc.contributor.authorDe Guia, Ten_US
dc.contributor.authorShim, YSen_US
dc.contributor.authorChiang, CHen_US
dc.contributor.authorMangunnegoro, Hen_US
dc.date.accessioned2012-09-05T05:24:22Z-
dc.date.available2012-09-05T05:24:22Z-
dc.date.issued2005en_US
dc.identifier.citationRespirology, 2005, v. 10 n. 1, p. 9-17en_US
dc.identifier.issn1323-7799en_US
dc.identifier.urihttp://hdl.handle.net/10722/162850-
dc.description.abstractChronic obstructive pulmonary disease (COPD) is a major public health problem and its prevalence and mortality are increasing throughout the world, including the Asia-Pacific region. To arrest these worldwide trends, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Expert Panel's global strategy for the diagnosis, management, and prevention of COPD was published in 2001. Based on recently published clinical trials, the GOLD statement was updated in 2003. The Asia-Pacific COPD Roundtable Group, a taskforce of expert respirologists from the Asia-Pacific region, has recently formulated a consensus statement on implementation of the GOLD strategy for COPD in the Asia-Pacific region. The key issues identified by the COPD Roundtable Group for comment are: (i) where there is no access to spirometry, diagnosis of COPD could be suspected on the basis of history, symptoms and physical signs; (ii) inhaled bronchodilators are the preferred regular treatment for COPD in the region, but oral bronchodilators may be considered if the cost of inhaled bronchodilators is a barrier to treatment; (iii) the use of an Metered Dose Inhaler with spacer in place of a nebulizer is recommended in the treatment of acute airflow obstruction in patients with COPD; (iv) influenza vaccination is recommended for all patients with COPD in communities where there is a high likelihood of Severe Acute Respitory Syndrome; and (v) simplified pulmonary rehabilitation programmes should be established in areas where comprehensive programmes are unavailable. Physical exercise training and education on smoking cessation should be core elements of any rehabilitation program. In summary, the COPD Roundtable Group supports, implementation of the GOLD strategy for the diagnosis, management and prevention of COPD in the Asia-Pacific region, subject to the additions and modifications to the guidelines suggested above.en_US
dc.languageengen_US
dc.publisherBlackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/RESen_US
dc.relation.ispartofRespirologyen_US
dc.subjectAsia-
dc.subjectBronchodilators-
dc.subjectChronic obstructive pulmonary disease-
dc.subjectGlobal Initiative for Chronic Obstructive Lung Disease statement-
dc.subjectInfluenza vaccination-
dc.subjectPulmonary rehabilitation-
dc.subjectSevere Acute Respitory Syndrome-
dc.subjectSpirometry-
dc.subject.meshAsiaen_US
dc.subject.meshAustraliaen_US
dc.subject.meshBronchodilator Agents - Administration & Dosage - Therapeutic Useen_US
dc.subject.meshHumansen_US
dc.subject.meshInfluenza Vaccinesen_US
dc.subject.meshInternational Cooperationen_US
dc.subject.meshPhysical Therapy Modalitiesen_US
dc.subject.meshPulmonary Disease, Chronic Obstructive - Diagnosis - Prevention & Control - Rehabilitation - Therapyen_US
dc.subject.meshSpirometryen_US
dc.subject.meshVaccinationen_US
dc.subject.meshWorld Healthen_US
dc.titleGlobal Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: An Asia-Pacific perspectiveen_US
dc.typeArticleen_US
dc.identifier.emailIp, M:msmip@hku.hken_US
dc.identifier.authorityIp, M=rp00347en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1440-1843.2005.00692.xen_US
dc.identifier.pmid15691232-
dc.identifier.scopuseid_2-s2.0-20044364929en_US
dc.identifier.hkuros97430-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-20044364929&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume10en_US
dc.identifier.issue1en_US
dc.identifier.spage9en_US
dc.identifier.epage17en_US
dc.publisher.placeAustraliaen_US
dc.identifier.scopusauthoridWan, CT=8723525000en_US
dc.identifier.scopusauthoridMahayiddin, AA=22935161400en_US
dc.identifier.scopusauthoridCharoenratanakul, S=6701368114en_US
dc.identifier.scopusauthoridZhong, NS=7102137996en_US
dc.identifier.scopusauthoridSeale, P=24529032700en_US
dc.identifier.scopusauthoridIp, M=7102423259en_US
dc.identifier.scopusauthoridDe Guia, T=15041663800en_US
dc.identifier.scopusauthoridShim, YS=7101785913en_US
dc.identifier.scopusauthoridChiang, CH=7402434394en_US
dc.identifier.scopusauthoridMangunnegoro, H=6505897768en_US
dc.identifier.issnl1323-7799-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats